The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculature

Cancer Lett. 2012 Dec 30;326(2):161-7. doi: 10.1016/j.canlet.2012.08.002. Epub 2012 Aug 16.

Abstract

3-Hydroxiglutaric acid (3-OH-GA) is a disease-specific metabolite that accumulates in tissues and body fluids of patients with Glutaric aciduria type I (GAI) and has been associated with vascular abnormalities in these kindreds. Here, we demonstrate that 3-OH-GA also affects the integrity of tumor vessels leading to tumor growth inhibition in a subcutaneous model of human glioblastoma multiforme (GBM). This effect correlated with a marked decrease of VE-Cadherin expression in endothelium of 3-OH-GA-treated tumors. Furthermore, in vitro observations indicated also a direct effect of 3-OH-GA in glioma cells that showed defective mitosis and significant proliferation inhibition. In summary, the GAI-specific metabolite 3-OH-GA significantly inhibited growth of GBM xenografts by affecting the structural integrity of tumor blood vessels and in addition by causing defective mitosis and proliferation inhibition of tumor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Vessels / drug effects
  • Cell Division / drug effects*
  • Cell Line, Tumor
  • DNA, Complementary
  • Glioblastoma / blood supply
  • Glioblastoma / pathology*
  • Glutarates / pharmacology*
  • Humans
  • Immunohistochemistry
  • Mice
  • Mice, Nude
  • Neovascularization, Pathologic*
  • Oligonucleotide Array Sequence Analysis

Substances

  • 3-hydroxyglutaric acid
  • DNA, Complementary
  • Glutarates